Reuters -- Northfield Laboratories, whose human red blood cell substitute was denied U.S. regulatory approval, filed for bankruptcy protection on Monday to liquidate its assets.
Reuters -- Northfield Laboratories, whose human red blood cell substitute was denied U.S. regulatory approval, filed for bankruptcy protection on Monday to liquidate its assets.
